249 related articles for article (PubMed ID: 4213979)
1. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
Mates A; Zand P
J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
[TBL] [Abstract][Full Text] [Related]
2. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
[TBL] [Abstract][Full Text] [Related]
3. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
Lieberman MM; Ayala E
J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
[No Abstract] [Full Text] [Related]
4. Experimental immunization with attenuated mutants of Pseudomonas aeruginosa.
Syeklocha D
Can J Microbiol; 1973 May; 19(5):573-80. PubMed ID: 4196781
[No Abstract] [Full Text] [Related]
5. Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa.
Johnston LJ; Syeklocha D
Can J Microbiol; 1972 Oct; 18(10):1607-11. PubMed ID: 4628185
[No Abstract] [Full Text] [Related]
6. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
Iushkova NA; Stanislavskiĭ ES; Landsman NM
Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
[TBL] [Abstract][Full Text] [Related]
7. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
8. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
Lieberman MM; McKissock DC; Wright GL
Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the protective properties of antisera and immunoglobulin to antigens of Pseudomonas aeruginosa slime].
Zaĭdner IG; Stanislavskiĭ ES; Gladus MA
Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):52-7. PubMed ID: 6778023
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
11. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4].
Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI
Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515
[TBL] [Abstract][Full Text] [Related]
12. Effect of active and passive immunization on the development of experimental Pseudomonas aeruginosa pyelonephritis in mice.
Petit JC; Sicard D; Bayo S; Daguet GL
Can J Microbiol; 1981 Jan; 27(1):93-7. PubMed ID: 6783287
[TBL] [Abstract][Full Text] [Related]
13. Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.
Lieberman MM; Wright GL; Wolcott KM; McKissock-Desoto DC
Infect Immun; 1980 Aug; 29(2):489-93. PubMed ID: 6783532
[TBL] [Abstract][Full Text] [Related]
14. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.
Jones RJ
Br J Exp Pathol; 1968 Oct; 49(5):411-20. PubMed ID: 4973304
[No Abstract] [Full Text] [Related]
15. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
Lieberman MM; Walker HL; Ayala E; Chapa I
J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
[TBL] [Abstract][Full Text] [Related]
16. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
Jones RJ; Roe EA
Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544
[TBL] [Abstract][Full Text] [Related]
17. Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.
Jones RJ; Hall M; Ricketts CR
Immunology; 1972 Dec; 23(6):889-95. PubMed ID: 4630781
[TBL] [Abstract][Full Text] [Related]
18. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
Sokalska M; Maresz-Babczyszyn J
Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
[TBL] [Abstract][Full Text] [Related]
19. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM
Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
[TBL] [Abstract][Full Text] [Related]
20. The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.
Sensakovic JW; Bartell PF
J Infect Dis; 1974 Feb; 129(2):101-9. PubMed ID: 4204237
[No Abstract] [Full Text] [Related]
[Next] [New Search]